NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2024
DOI: 10.1152/ajpgi.00233.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2024. Verfasst von Andrew J King und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ardelyx, Inc., Waltham, Massachusetts, United States. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Isoquinolines, Sulfonamides. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ardelyx, Inc..
Abstract (Originalsprache)
A series of nonclinical experiments support the theory that tenapanor inhibits IBS-C-related pain by strengthening the intestinal barrier. Tenapanor treatment reduced visceral motor responses to nonsensitized levels in two rat models of hypersensitivity and reduced responses to capsaicin in sensitized colonic nociceptive dorsal root ganglia neurons. Intestinal permeability experiments in human colon monolayer cultures found that tenapanor attenuates increases in permeability induced by either inflammatory cytokines or fecal supernatants from patients with IBS-C.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ardelyx, Inc., Waltham, Massachusetts, United States.
- Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States.
- Division of Gastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
ORCID-Profile: Kenji Kozuka
Förderung
- Ardelyx, Inc.
Zitieren
APA
King, A. J., Chang, L., Li, Q., Liu, L., Zhu, Y., Pasricha, P. J., Wang, J., Siegel, M., Caldwell, J. S., Edelstein, S., Rosenbaum, D. P., & Kozuka, K. (2024). NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00233.2023
Vancouver
King AJ, Chang L, Li Q, Liu L, Zhu Y, Pasricha PJ, et al. NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024. doi:10.1152/ajpgi.00233.2023
BibTeX
@article{King2024,
author = {King, Andrew J and Chang, Lin and Li, Qian and Liu, Liansheng and Zhu, Yaohui and Pasricha, Pankaj J and Wang, Ji and Siegel, Matthew and Caldwell, Jeremy S and Edelstein, Susan and Rosenbaum, David P and Kozuka, Kenji},
title = {NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2024},
doi = {10.1152/ajpgi.00233.2023}
}
EUVIMED